Artificial Intelligence Unlocks New Possibilities in Anti-Aging Medicine

Source: Google News - HealthArtificial intelligence can be used to identify new senolytic compounds, according to a study published in the journal Nature Aging. Senolytic compounds are a class of small molecules have the potential to inhibit aging-related processes like fibrosis, inflammation, and cancer. For the study, Harvard and MIT researchers screened 2,352 compounds to predict the senolytic activities of more than 800,000 molecules, and found several promising leads.